Bonn-Miller MO - Search Results

1

A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal cannabidiol (ZYN002) for the treatment of pediatric fragile X syndrome.

Heussler H, Cohen J, Silove N, Tich N, Bonn-Miller MO, Du W, O'Neill C, Sebree T. Heussler H, et al. J Neurodev Disord. 2019 Aug 2;11(1):16. doi: 10.1186/s11689-019-9277-x. J Neurodev Disord. 2019. PMID: 31370779 Free PMC article. Clinical Trial.

2

Conversion of Cannabidiol Following Oral Administration: Authors' Response to Grotenhermen et al. DOI: 10.1089/can.2016.0036.

Bonn-Miller MO, Banks SL, Sebree T. Bonn-Miller MO, et al. Cannabis Cannabinoid Res. 2017 Jan 1;2(1):5-7. doi: 10.1089/can.2016.0038. eCollection 2017. Cannabis Cannabinoid Res. 2017. PMID: 28861500 Free PMC article.

3

Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism.

Zieba J, Sinclair D, Sebree T, Bonn-Miller M, Gutterman D, Siegel S, Karl T. Zieba J, et al. Pharmacol Biochem Behav. 2019 Jun;181:93-100. doi: 10.1016/j.pbb.2019.05.002. Epub 2019 May 4. Pharmacol Biochem Behav. 2019. PMID: 31063743

4

Practical considerations for testing the effects of cannabidiol on human anxiety.

Leen-Feldner EW, Bynion TM, Gournay R, Bonn-Miller MO, Feldner MT. Leen-Feldner EW, et al. J Anxiety Disord. 2021 Aug;82:102429. doi: 10.1016/j.janxdis.2021.102429. Epub 2021 May 24. J Anxiety Disord. 2021. PMID: 34058457 Free article.

5

Adjunctive Transdermal Cannabidiol for Adults With Focal Epilepsy: A Randomized Clinical Trial.

O'Brien TJ, Berkovic SF, French JA, Messenheimer JA, Sebree TB, Bonn-Miller MO, Gutterman DL; STAR 1/STAR 2 Study Group. O'Brien TJ, et al. JAMA Netw Open. 2022 Jul 1;5(7):e2220189. doi: 10.1001/jamanetworkopen.2022.20189. JAMA Netw Open. 2022. PMID: 35802375 Free PMC article. Clinical Trial.

6

Oral Cannabidiol Treatment in Two Postmenopausal Women with Osteopenia: A Case Series.

Kulpa J, Harrison A, Rudolph L, Eglit GML, Turcotte C, Bonn-Miller MO, Peters EN. Kulpa J, et al. Cannabis Cannabinoid Res. 2023 Sep;8(S1):S83-S89. doi: 10.1089/can.2023.0060. Cannabis Cannabinoid Res. 2023. PMID: 37721991 Clinical Trial.

7

Treatment of Fragile X Syndrome with Cannabidiol: A Case Series Study and Brief Review of the Literature.

Tartaglia N, Bonn-Miller M, Hagerman R. Tartaglia N, et al. Cannabis Cannabinoid Res. 2019 Mar 13;4(1):3-9. doi: 10.1089/can.2018.0053. eCollection 2019. Cannabis Cannabinoid Res. 2019. PMID: 30944868 Free PMC article. Review.

8

Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Yellow Oil in Healthy Participants.

Peters EN, Mosesova I, MacNair L, Vandrey R, Land MH, Ware MA, Turcotte C, Bonn-Miller MO. Peters EN, et al. J Anal Toxicol. 2022 Apr 21;46(4):393-407. doi: 10.1093/jat/bkab026. J Anal Toxicol. 2022. PMID: 33710277 Free PMC article. Clinical Trial.

9

Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Red Softgels in Healthy Participants.

Peters EN, Mosesova I, MacNair L, Vandrey R, Land MH, Ware MA, Turcotte C, Bonn-Miller MO. Peters EN, et al. J Anal Toxicol. 2022 May 20;46(5):528-539. doi: 10.1093/jat/bkab035. J Anal Toxicol. 2022. PMID: 33848338 Free PMC article. Clinical Trial.

10

Effect of Cannabidiol on the Long-Term Toxicity and Lifespan in the Preclinical Model Caenorhabditis elegans.

Land MH, Toth ML, MacNair L, Vanapalli SA, Lefever TW, Peters EN, Bonn-Miller MO. Land MH, et al. Cannabis Cannabinoid Res. 2021 Dec;6(6):522-527. doi: 10.1089/can.2020.0103. Epub 2020 Nov 20. Cannabis Cannabinoid Res. 2021. PMID: 33998871 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters